MondayNightIBD
April 2024 - March 2025
This activity is jointly provided by Global Education Group and Bonum CE in partnership with MondayNightIBD.
Program Overview
The management of inflammatory bowel disease (IBD) is an ever-evolving field. The past decade of developments has led to improved understanding of the disease, management focus beyond symptom control, emphasis on preventing disease progression while avoiding bowel damage and disability, new therapeutic options, and improved treatment algorithms. Additionally, with the rapid and ongoing expansion of IBD therapies (including several characterized by novel mechanisms of action) clinicians are faced with the task of ensuring that their knowledge of the full spectrum of available therapies is both accurate and up to date all the while recognizing nuance in guidelines, patient preferences in a constantly evolving field.
MondayNightIBD, is a serialized CME-certified program that addresses many of these complex clinical questions through our bi-weekly, Twitter-based Clinical Conversations, #PatientExperience Conversations, #Back2Basics Tweetorials, and wrap-up Algorithms.
Program Chair
Aline Charabaty, MD, FACG, AGAF (moderator)
Associate Professor of Medicine
Johns Hopkins School of Medicine
Medical Director of the Division of Gastroenterology and Hepatology
Clinical Director of the IBD Center at Johns Hopkins
Sibley Memorial Hospital
Washington, D.C.
Schedule
| Activity Date | Topic | Faculty | Disclosures | Supported by educationalal grants from... | Pre-test Link | Post-test Link | LOs |
|---|---|---|---|---|---|---|---|
| April 15, 2024 | Post-op Crohn's & Scoring Systems #Back2Basics | Mehak Bassi, MD Second-year Gastroenterology Fellow Saint Peter's University Hospital, New Brunswick, NJ | Nothing to disclose | AbbVie and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC | here | here | 1,2,3 |
| April 22, 2024 | Management of Crohn's in the Post-op Setting | Benjamin Click, MD, MS Assistant Professor of Medicine University of Colorado Crohn’s and Colitis Center Division of Gastroenterology & Hepatology University of Colorado School of Medicine Aurora, CO | Consulting Fees: AbbVie, Bristol Meyers Squibb, Janssen, Prometheus, Pfizer, Takeda, TARGET-RWE | AbbVie and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC | here | here | 2, 3, 7 |
| April 29, 2024 | Perianal Disease #Back2Basics | Ifrah Fatima, MBBS Resident Physician, Internal Medicine University of Missouri- Kansas City Kansas City, MO Dheera Grover, MD GI fellow Allegheny General Health Pittsburgh, PA | Nothing to disclose Nothing to disclose | ||||
| May 6, 2024 | Clinical Case Convo: topic TBD | Phillip Fleshner, MD, FASCRS Professor Medical Director, Colorectal Surgery Research Shierley, Jesslyne, and Emmeline Widjaja Chair in Colorectal Surgery Los Angeles, CA | tbd |
Target Audience
Gastroenterologists (GIs), GIs in training, surgeons, subspecialists such as dieticians and psychologists, nurse practitioners (NPs), physician assistants (PAs), nurses, and other healthcare team members involved in or interested in the care of patients with IBD.
Learning Objectives
After completing this activity series, learners should be better able to:
1. RECOGNIZE the importance of targeting objective measures of IBD activity
2. ANALYZE evidence-based guidelines for the management of patients with IBD
3. ASSESS optimization strategies for treatment, including the appropriate positioning of therapies, to enhance outcomes for patients with IBD
4. EVALUATE the clinical safety and efficacy data for newly approved and emerging therapies for patients with IBD
5. OUTLINE the efficacy, safety, and formulation of biosimilar products including interchangeability, along with impacts of switches in therapies for patients with IBD
6. RECOGNIZE symptoms of IBD that extend beyond commonly discussed manifestations, emphasizing those that hold particular significance for patients
7. DEVELOP comprehensive strategies for managing challenging cases of IBD, incorporating multidisciplinary approaches as needed
8. UTILIZE educational initiatives leveraging crowdsourcing to enhance the quality of care for patients with IBD
9. ANALYZE disparities in the provision of IBD care and their implications for patient outcomes
10. IDENTIFY challenges faced by both patients and caregivers in coping with IBD
11. IMPLEMENT effective communication to facilitate shared decision-making and patient-centered care for individuals with IBD
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
-
Aline Charabaty, MD, (chair)
Consulting: AbbVie, Janssen, Eli Lilly, Pfizer, Takeda -
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
Bonum CE staff and others involved with the planning, development, and review of the content for this activity have no relevant financial relationships to disclose.
Certification
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Bonum Continuing Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions to Receive Credit & Fee Information
In order to receive credit for this activity, the participant must read the front matter, achieve a passing score of 100% on the post-survey, complete the evaluation and application for credit form.
Completion of the above referenced materials must be submitted to the program organizers within one year of the case conversation launch date. Requests for credit made more than 12 months following each activity posting date will not be eligible for a certificate. The organizers encourage learners, particularly those with regular participation in MondayNightIBD activities, to complete post-surveys, evaluation & credit claim forms on a weekly or monthly basis if at all possible.
There is no fee to participate in this program.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group, collaborators, and faculty on this program do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimers
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
System Requirements
All Bonum CE digital activities require the following hardware/software to view and participate:
Internet connection (via PC or Mac desktop or laptop computer, tablet, mobile device, etc.)
PowerPoint and/or a PDF viewer may be required on some activities
We recommend a minimum of:
128MB RAM
Processor speed of 500MHz or higher
800x600 color monitor
Video or graphics card
Sound card and speakers
To actively participate in Bonum’s social media (SoMe)-based CME programs, learners will need to have an established account in good standing on that hosting SoMe site. Learners will need to be logged-in to the SoMe hosting platform.
Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Estimated time to complete each activity: 60 minutes